70 related articles for article (PubMed ID: 10491310)
1. Cyclosporine downregulates Fas ligand expression on vascular endothelial cells: implication for accelerated vasculopathy by immunosuppressive therapy.
Sata M; Walsh K
Biochem Biophys Res Commun; 1999 Sep; 263(2):430-2. PubMed ID: 10491310
[TBL] [Abstract][Full Text] [Related]
2. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
[TBL] [Abstract][Full Text] [Related]
3. Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia.
Sata M; Luo Z; Walsh K
J Immunol; 2001 Jun; 166(11):6964-71. PubMed ID: 11359858
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ
Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients.
Ovuworie CA; Fox ER; Chow CM; Pascual M; Shih VE; Picard MH; Tolkoff-Rubin NE
Transplantation; 2001 Oct; 72(8):1385-8. PubMed ID: 11685108
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of ischemia/reperfusion injury to endothelial cells by cyclosporin A.
Azizian M; Ramenaden ER; Shah G; Wilasrusmee C; Bruch D; Kittur DS
Am Surg; 2004 May; 70(5):438-42. PubMed ID: 15156953
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine triggers endoplasmic reticulum stress in endothelial cells: a role for endothelial phenotypic changes and death.
Bouvier N; Flinois JP; Gilleron J; Sauvage FL; Legendre C; Beaune P; Thervet E; Anglicheau D; Pallet N
Am J Physiol Renal Physiol; 2009 Jan; 296(1):F160-9. PubMed ID: 18987109
[TBL] [Abstract][Full Text] [Related]
8. A new in vitro model to study endothelial injury.
Wilasrusmee C; Da Silva M; Singh B; Kittur S; Siddiqui J; Bruch D; Wilasrusmee S; Kittur DS
J Surg Res; 2002 May; 104(2):131-6. PubMed ID: 12020132
[TBL] [Abstract][Full Text] [Related]
9. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
10. TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation.
Sata M; Walsh K
Nat Med; 1998 Apr; 4(4):415-20. PubMed ID: 9546786
[TBL] [Abstract][Full Text] [Related]
11. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand mRNA levels of circulating leukocytes reflect endothelial dysfunction in hyperlipidemic but not in non-hyperlipidemic patients.
Kotani N; Fukuo K; Yasuda O; Sugimoto K; Katuya T; Takemura Y; Kawamoto H; Yokoi T; Suzuki A; Ogihara T
Hypertens Res; 2006 Apr; 29(4):217-25. PubMed ID: 16778328
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
[TBL] [Abstract][Full Text] [Related]
14. For organ transplant recipients, cancer threatens long-term survival.
Ross K
J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
[No Abstract] [Full Text] [Related]
15. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
Kalas W; Matuszyk J; Ziolo E; Strzadala L
Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelin-1 in microvascular dysfunction caused by cyclosporin A.
Wilasrusmee C; Da Silva M; Siddiqui J; Bruch D; Kittur S; Wilasrusmee S; Kittur DS
J Am Coll Surg; 2003 Apr; 196(4):584-91. PubMed ID: 12691936
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive-associated encephalopathy in bone marrow transplant recipients].
Ohta K; Yoritaka A; Sakamaki H; Kishida S;
No To Shinkei; 2004 May; 56(5):395-401. PubMed ID: 15279197
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Fas ligand expression by vascular endothelial growth factor in endometrial stromal cells in vitro.
Berkkanoglu M; Guzeloglu-Kayisli O; Kayisli UA; Selam BF; Arici A
Mol Hum Reprod; 2004 Jun; 10(6):393-8. PubMed ID: 15073283
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
